Haplo ever after: haplo PTCy for children.
作者信息
Talano Julie-An, Broglie Larisa
机构信息
Department of Pediatric Hematology Oncology and Bone Marrow Transplantation, Medical College of Wisconsin, Milwaukee, WI.
出版信息
Blood Adv. 2023 Sep 26;7(18):5637-5638. doi: 10.1182/bloodadvances.2023010755.
Abstract
摘要
相似文献
1
Haplo ever after: haplo PTCy for children.从此单倍体无忧：儿童单倍体PTCy治疗
Blood Adv. 2023 Sep 26;7(18):5637-5638. doi: 10.1182/bloodadvances.2023010755.
2
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.移植后环磷酰胺与常规移植物抗宿主病预防后移植物抗宿主病（GVHD）的特征。
Transplant Cell Ther. 2022 Oct;28(10):681-693. doi: 10.1016/j.jtct.2022.07.013. Epub 2022 Jul 16.
3
Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation.与单倍体相合干细胞移植和脐带血移植相比具有可比的生存结果。
Bone Marrow Transplant. 2022 Nov;57(11):1681-1688. doi: 10.1038/s41409-022-01770-y. Epub 2022 Aug 20.
4
Effect of Donor NKG2D Polymorphism on Relapse after Haploidentical Transplantation with Post-Transplantation Cyclophosphamide.供者 NKG2D 多态性对移植后环磷酰胺后单倍体相合移植后复发的影响。
Transplant Cell Ther. 2022 Jan;28(1):20.e1-20.e10. doi: 10.1016/j.jtct.2021.09.019. Epub 2021 Oct 1.
5
Increased Infections and Delayed CD4 T Cell but Faster B Cell Immune Reconstitution after Post-Transplantation Cyclophosphamide Compared to Conventional GVHD Prophylaxis in Allogeneic Transplantation.移植后环磷酰胺与常规移植物抗宿主病预防相比，异体移植后感染增加且 CD4 T 细胞恢复延迟，但 B 细胞免疫恢复更快。
Transplant Cell Ther. 2021 Nov;27(11):940-948. doi: 10.1016/j.jtct.2021.07.023. Epub 2021 Jul 28.
6
Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.单倍体脐带血移植与单倍体相合移植加移植后环磷酰胺治疗 AML 患者的比较。
Bone Marrow Transplant. 2017 Aug;52(8):1138-1143. doi: 10.1038/bmt.2017.36. Epub 2017 Mar 27.
7
Effect of Graft-versus-Host Disease on Post-Transplantation Outcomes following Single Cord Blood Transplantation Compared with Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Adult Acute Myeloid Leukemia.单份脐带血移植与环磷酰胺预处理的单倍体相合移植治疗成人急性髓系白血病：移植物抗宿主病对移植后结局的影响。
Transplant Cell Ther. 2023 Jun;29(6):365.e1-365.e11. doi: 10.1016/j.jtct.2023.03.001. Epub 2023 Mar 6.
8
Impact of the Addition of Antithymocyte Globulin to Post-Transplantation Cyclophosphamide in Haploidentical Transplantation with Peripheral Blood Compared to Post-Transplantation Cyclophosphamide Alone in Acute Myelogenous Leukemia: A Retrospective Study on Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.在异基因外周血造血干细胞移植中，与单纯移植后环磷酰胺相比，加用抗胸腺细胞球蛋白对急性髓系白血病的影响：欧洲血液和骨髓移植学会急性白血病工作组的一项回顾性研究。
Transplant Cell Ther. 2022 Sep;28(9):587.e1-587.e7. doi: 10.1016/j.jtct.2022.06.006. Epub 2022 Jun 14.
9
Comparable Outcomes for Hematologic Malignancies after HLA-Haploidentical Transplantation with Posttransplantation Cyclophosphamide and HLA-Matched Transplantation.接受移植后环磷酰胺的HLA单倍体相合移植与HLA匹配移植治疗血液系统恶性肿瘤的疗效相当。
Adv Hematol. 2015;2015:431923. doi: 10.1155/2015/431923. Epub 2015 Dec 2.
10
Outcome of Haploidentical Peripheral Blood Allografts Using Post-Transplantation Cyclophosphamide Compared to Matched Sibling and Unrelated Donor Bone Marrow Allografts in Pediatric Patients with Hematologic Malignancies: A Single-Center Analysis.与匹配同胞及无关供者骨髓移植相比，应用移植后环磷酰胺的单倍体相合外周血移植治疗儿童血液系统恶性肿瘤的疗效：一项单中心分析
Transplant Cell Ther. 2022 Mar;28(3):158.e1-158.e9. doi: 10.1016/j.jtct.2021.11.009. Epub 2021 Nov 25.
本文引用的文献
1
Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemias.前瞻性 PTCTC 试验：亲缘单倍体相合 BMT 联合移植后环磷酰胺治疗儿科急性白血病。
Blood Adv. 2023 Sep 26;7(18):5639-5648. doi: 10.1182/bloodadvances.2023010281.
2
Outcomes of Unmanipulated Haploidentical Transplantation Using Post-Transplant Cyclophosphamide (PT-Cy) in Pediatric Patients With Acute Lymphoblastic Leukemia.未预处理的单倍体相合移植联合移植后环磷酰胺（PT-Cy）在急性淋巴细胞白血病儿科患者中的疗效。
Transplant Cell Ther. 2021 May;27(5):424.e1-424.e9. doi: 10.1016/j.jtct.2021.01.016. Epub 2021 Jan 21.
3
Haploidentical Stem Cell Transplantation With Post-transplant Cyclophosphamide for Pediatric Acute Leukemia is Safe and Effective.采用移植后环磷酰胺的单倍体相合干细胞移植治疗儿童急性白血病安全有效。
J Pediatr Hematol Oncol. 2021 Oct 1;43(7):e1033-e1036. doi: 10.1097/MPH.0000000000002030.
4
Myeloablative haploidentical BMT with posttransplant cyclophosphamide for hematologic malignancies in children and adults.清髓性单倍体相合 BMT 联合移植后环磷酰胺治疗儿童和成人血液系统恶性肿瘤。
Blood Adv. 2020 Aug 25;4(16):3913-3925. doi: 10.1182/bloodadvances.2020001648.
5
T-Cell Replete Myeloablative Haploidentical Bone Marrow Transplantation Is an Effective Option for Pediatric and Young Adult Patients With High-Risk Hematologic Malignancies.T细胞充足的清髓性单倍体相合骨髓移植是高危血液系统恶性肿瘤儿科及年轻成人患者的有效选择。
Front Pediatr. 2020 Jun 9;8:282. doi: 10.3389/fped.2020.00282. eCollection 2020.
6
Haploidentical transplantation in high-risk pediatric leukemia: A retrospective comparative analysis on behalf of the Spanish working Group for bone marrow transplantation in children (GETMON) and the Spanish Grupo for hematopoietic transplantation (GETH).高危型儿科白血病的单倍体移植：西班牙儿童骨髓移植工作组（GETMON）和西班牙造血移植组（GETH）的回顾性对比分析。
Am J Hematol. 2020 Jan;95(1):28-37. doi: 10.1002/ajh.25661. Epub 2019 Nov 5.
7
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation.非清髓性、HLA 单倍体相合骨髓移植后短程他克莫司。
Biol Blood Marrow Transplant. 2018 May;24(5):1022-1028. doi: 10.1016/j.bbmt.2018.01.011. Epub 2018 Jan 17.
8
Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor-Mobilized Donor Lymphocyte Infusions.采用清髓性预处理、基于移植后环磷酰胺的单倍体相合移植及早期预防性粒细胞集落刺激因子动员的供者淋巴细胞输注后，难治性/复发性急性髓系白血病的预后改善。
Biol Blood Marrow Transplant. 2016 Oct;22(10):1867-1873. doi: 10.1016/j.bbmt.2016.07.016. Epub 2016 Jul 25.
9
Feasibility and Outcome of Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant High-Dose Cyclophosphamide for Children and Adolescents with Hematologic Malignancies: An AIEOP-GITMO Retrospective Multicenter Study.单倍型相合造血干细胞移植联合移植后大剂量环磷酰胺治疗儿童和青少年血液系统恶性肿瘤的可行性及疗效：一项AIEOP - GITMO回顾性多中心研究
Biol Blood Marrow Transplant. 2016 May;22(5):902-9. doi: 10.1016/j.bbmt.2016.02.002. Epub 2016 Feb 6.
10
Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide.使用移植后环磷酰胺进行来自部分人类白细胞抗原（HLA）不匹配相关供者的非清髓性骨髓移植。
Biol Blood Marrow Transplant. 2002;8(7):377-86. doi: 10.1053/bbmt.2002.v8.pm12171484.
Zotero 插件